Navigation Links
Aspartame passes stiff review by European Food Safety Authority
Date:12/11/2013

(Dec. 10) The widely used no-calorie sweetener, aspartame, has been deemed safe for consumption at current levels by the European Food Safety Authority (EFSA), which conducted one of the most comprehensive risk assessments ever undertaken. EFSA's opinion echoes those of numerous government agencies, including the Food and Drug Administration. EFSA also concluded that:

  • Aspartame can be used by pregnant women.
  • Aspartame does not cause cancer, harm the brain or nervous system or affect behavior or cognitive function of children or adults.

Low and no-calorie sweeteners, including aspartame, have also been reviewed by The American Heart Association, the American Diabetes Association and the American Academy of Nutrition and Dietetics, which have found them to be safe and effective.


'/>"/>

Contact: Michael Schiferl
mschiferl@webershandwick.com
312-988-2017
Weber Shandwick
Source:Eurekalert

Page: 1

Related biology news :

1. West Nile virus passes from female to eggs, but less so from larvae to adults
2. Afterburn Fuel Review Announces the Launch of its New and Informative Website
3. Cranberries have health-promoting properties, new expert review reveals
4. New report reviews science and engineering quality at national security laboratories
5. Review outlines best practice standards for coordinator-based fracture liaison services
6. Study explores effects of review setting on scientific peer review
7. Prohormonesdirect.com Offers in Depth OxyELITE Pro Reviews
8. Fat Loss Factor Review Gives Opinion of Popular Weight Loss Program
9. Detailed Flex Belt Review and Announcement of New Discount Coupon at Flex Belt Critic Site
10. 3-D Printing and Additive Manufacturing preview issue publishing Fall 2013
11. New review sets international standards for best practice in fracture liaison services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2015)... 18, 2015  Cepheid (NASDAQ: CPHD ) today ... conferences, and invited investors to participate via webcast. , ... Tuesday, March 3, 2015 at 11.20 a.m. Eastern ... Orlando, FL Wednesday, March 4, 2015 at 10.25 ... the live webcasts for these events, please visit Cepheid,s website ...
(Date:2/11/2015)... , February 11, 2015 ... report "Access Control Market by Product (Cards and Readers, ... Military and Defense, Government, Industrial, Healthcare, Education) and By ... by MarketsandMarkets, the Access Control Market is ... growing at a CAGR of 10.6% between ...
(Date:2/5/2015)... , Feb. 5, 2015  Marken is starting ... company and has launched a new marketing campaign to ... Organization (CLO).  The new campaign focuses on First ... protocol and shipments. The first headline in ... aligns Marken,s priorities with its client,s priorities. Marken recognizes ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Marken Launches New Patient-Centric Campaign 2
... day of competition in London, a team of four ... emerged as the winners of this year,s Biotechnology Young ... Biotechnology Young Entrepreneurs Scheme (YES) competition are Ben Owens, ... University of Oxford. The team pitched their ...
... Stem cell scientists at King,s College London will today ... UK Stem Cell Bank (UKSCB) their first clinical grade ... from animal-derived products, known as ,xeno-free, stem cells. ... ,gold standard, lines for developing new stem cell-based therapies, ...
... Darrel Tremaine has been known to go to extremes for ... through a dark, muddy limestone cave in Northwest Florida to ... His goal? To compare ancient meteorological patterns with modern ones ... policymakers on how to build a sustainable water supply. ...
Cached Biology News:Winning early-career researchers excel in entrepreneurship 2Winning early-career researchers excel in entrepreneurship 3Stem cell research in the UK reaches significant milestone 2Stem cell research in the UK reaches significant milestone 3Stem cell research in the UK reaches significant milestone 4Researcher finds key to ancient weather patterns in Florida's caves 2Researcher finds key to ancient weather patterns in Florida's caves 3Researcher finds key to ancient weather patterns in Florida's caves 4
(Date:2/27/2015)... , Feb. 27, 2015 Bionomics Limited (ASX:BNO, ... DisrupTOR-1 trial of BNC105 in patients with metastatic renal ... Orlando, Florida . The data will be ... City of Hope Comprehensive Cancer Center in ... The new data identifies Ferritin and IL-8 as ...
(Date:2/27/2015)... South San Francisco, CA (PRWEB) February 27, 2015 ... it is joining forces on February 28 with patients ... globally to raise awareness for Rare Disease Day®. ... of rare diseases and calling attention to the special ... support community around them. , “Cytokinetics is proud to ...
(Date:2/26/2015)... , Feb. 26, 2015 S&P Capital IQ ... Stock Report coverage on MabVax Therapeutics Holdings Inc . ... a clinical stage biotechnology company focused on the development ... needs in the treatment of cancer. MabVax has discovered ... the protective immune responses generated by patients who have ...
(Date:2/26/2015)... TORONTO , Feb. 26, 2015 /PRNewswire/ - SQI ... SQIDF), a life sciences company that develops and commercializes ... reported its financial and operational results for the fiscal ... this press release are in Canadian dollars (CAD), unless ... Company continued to win new business from our existing ...
Breaking Biology Technology:New BNC105 Biomarker Data to be Presented at US Cancer Conference 2New BNC105 Biomarker Data to be Presented at US Cancer Conference 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 4New BNC105 Biomarker Data to be Presented at US Cancer Conference 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 2Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 4Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 6S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5SQI Diagnostics Reports First Quarter Financial Results 2SQI Diagnostics Reports First Quarter Financial Results 3SQI Diagnostics Reports First Quarter Financial Results 4SQI Diagnostics Reports First Quarter Financial Results 5SQI Diagnostics Reports First Quarter Financial Results 6
... Company Posts Fourth Quarter EPS of $0.37, Up 16% -, - For ... Up 41%; Total Revenues and Product ... Income Growth in Four Years, ... $1.72 -, SAN DIEGO, Feb. 13 Gen-Probe Incorporated,(Nasdaq: GPRO ...
... Inverness Medical,Innovations (Amex: IMA ) today announced ... was successfully completed on February 12,2008. BBI, located ... manufacture of non-invasive lateral flow tests and has ... reagents. The,final purchase price consisted of cash of ...
... 13 The following statement,is attributable to Kathy ... Control and Epidemiology (APIC):, "APIC is concerned ... as high as 70 percent according to recent ... strain, provide evidence that,the very nature of these ...
Cached Biology Technology:Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 2Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 3Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 4Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 5Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 6Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 7Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 8Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 9Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 10Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 11Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 12Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 13Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 14Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 15Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 16APIC Statement on Need for Increased Prevention Measures for Healthcare-Associated Infections (HAIs) 2